NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,739,909 | -18.8% | 1,078,868 | -10.7% | 0.05% | -15.5% |
| Q2 2023 | $58,814,710 | -11.3% | 1,208,687 | +1.2% | 0.06% | -13.4% |
| Q1 2023 | $66,312,255 | +35.7% | 1,194,385 | -1.8% | 0.07% | +28.8% |
| Q4 2022 | $48,877,329 | -7.4% | 1,216,762 | +1.0% | 0.05% | -11.9% |
| Q3 2022 | $52,809,000 | +23.8% | 1,205,141 | +0.2% | 0.06% | +34.1% |
| Q2 2022 | $42,641,000 | -13.0% | 1,203,157 | -0.2% | 0.04% | +4.8% |
| Q1 2022 | $49,024,000 | -54.0% | 1,205,110 | +5.5% | 0.04% | -26.3% |
| Q4 2021 | $106,636,000 | -17.1% | 1,141,840 | -1.1% | 0.06% | -19.7% |
| Q3 2021 | $128,685,000 | -1.8% | 1,154,750 | +0.1% | 0.07% | +2.9% |
| Q2 2021 | $130,989,000 | +13.2% | 1,153,785 | +1.2% | 0.07% | +16.9% |
| Q1 2021 | $115,726,000 | +5.7% | 1,139,704 | +3.6% | 0.06% | +9.3% |
| Q4 2020 | $109,511,000 | +28.6% | 1,100,387 | -6.7% | 0.05% | +3.8% |
| Q3 2020 | $85,172,000 | +40.5% | 1,179,029 | -3.0% | 0.05% | +20.9% |
| Q2 2020 | $60,631,000 | +65.0% | 1,216,014 | -1.2% | 0.04% | +34.4% |
| Q1 2020 | $36,748,000 | +11.3% | 1,230,659 | +25.6% | 0.03% | +33.3% |
| Q4 2019 | $33,003,000 | +15.7% | 979,620 | +12.7% | 0.02% | 0.0% |
| Q3 2019 | $28,515,000 | -18.6% | 869,385 | -31.6% | 0.02% | -22.6% |
| Q2 2019 | $35,033,000 | -1.1% | 1,270,211 | -26.0% | 0.03% | -3.1% |
| Q1 2019 | $35,412,000 | +39.5% | 1,717,376 | -5.6% | 0.03% | +23.1% |
| Q4 2018 | $25,387,000 | -10.4% | 1,818,559 | +53.7% | 0.03% | +4.0% |
| Q3 2018 | $28,322,000 | +205.8% | 1,183,052 | +140.4% | 0.02% | +177.8% |
| Q2 2018 | $9,261,000 | +6376.2% | 492,072 | +3106.7% | 0.01% | – |
| Q1 2018 | $143,000 | +25.4% | 15,345 | +20.3% | 0.00% | – |
| Q4 2017 | $114,000 | -63.5% | 12,753 | -47.2% | 0.00% | – |
| Q3 2017 | $312,000 | +136.4% | 24,171 | +62.5% | 0.00% | – |
| Q1 2017 | $132,000 | -32.7% | 14,879 | -11.3% | 0.00% | – |
| Q4 2016 | $196,000 | -22.5% | 16,772 | -26.2% | 0.00% | – |
| Q3 2016 | $253,000 | +21.1% | 22,738 | +30.9% | 0.00% | – |
| Q2 2016 | $209,000 | -5.0% | 17,376 | -14.5% | 0.00% | – |
| Q3 2015 | $220,000 | – | 20,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |